Tocqueville Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Tocqueville Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-73,340	Closed	-$3.38M	–	862
2016 Q3	$3.38M	Buy	73,340 +3,650	+5%	+$206K	0.04%	349
2016 Q2	$3.56M	Buy	69,690 +2,850	+4%	+$142K	0.04%	338
2016 Q1	$2.83M	Buy	66,840 +32,915	+97%	+$1.68M	0.04%	350
2015 Q4	$2.66M	Buy	33,925 +1,000	+3%	+$57.8K	0.04%	376
2015 Q3	$1.33M	Buy	32,925 +10,900	+49%	+$577K	0.02%	506
2015 Q2	$1.15M	Buy	+22,025	New	+$1.1M	0.01%	547

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tocqueville Asset Management's ISEE Position: Q4 2016 in Review

Tocqueville Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 73,340 shares — an estimated $3.38M sold.

Tocqueville Asset Management first reported a position in ISEE in Q2 2015 and held it in 6 quarters. The position peaked at $3.56M in Q2 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

Tocqueville Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Tocqueville Asset Management sold 73,340 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $3.38M.
Tocqueville Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
Tocqueville Asset Management's IVERIC bio, Inc. Common Stock position peaked at $3.56M in Q2 2016.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.